Skip to content
Screener

G&A at other companies

Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$27.68M+9.5%
Hyperfine, Inc. logo
Hyperfine, Inc.HYPR
$3.91M+1.2%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$20.63M-69.0%

Other financials

Income statement

See full
Revenue$252.5M+3.1%
Operating income$19.4M-24.0%
Net income$1.7M+122%
EPS (diluted)$0.02+118%

Balance sheet

See full
Cash & equivalents$51.2M
Total debt$965.8M
Total equity$599.6M+272%
Total assets$1.8B

Cash flow

See full
Operating cash flow$2.9M+121%
CapEx$5.3M+431%
Free cash flow-$2.4M+84.1%

Valuation

See full
Market cap$1.1B-37.3%
Enterprise value$2.01B

Returns & leverage

See full
Debt / equity1.6×
Current ratio1.4×

Where this comes from

Reported directly by Lumexa Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Lumexa Imaging Holdings, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219480
Line itemTHREE MONTHS ENDEDMARCH 31, 2026THREE MONTHS ENDEDMARCH 31, 2025
Total revenues252,537245,001
OPERATING EXPENSES:
Cost of operations, excluding depreciation and amortization217,755208,397
General and administrative expenses20,33517,492
Depreciation and amortization9,9229,051
Loss (gain) on disposal of property and equipment137(162)
Total operating expenses248,149234,778
Equity in earnings of unconsolidated affiliates15,02415,318

Item 1. Financial Statements.

FAQ

What is Lumexa Imaging Holdings, Inc.'s G&A?
Lumexa Imaging Holdings, Inc. (LMRI) reported G&A of $20.34M in Q1 2026.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Ask your AI about Lumexa Imaging Holdings, Inc.'s g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude